Alex Appert
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms 7
- Cancer Research top 10%
- NF-κB Signaling Pathways 4
-
- Genomics and Chromatin Dynamics 4
- CRISPR and Genetic Engineering 3
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
-
- Lymphoma Diagnosis and Treatment 3
-
- CAR-T cell therapy research 2
- Co-authors
- Julie AhringerPrzemysław StemporDong YanRifat HamoudiNi HuangMing‐Qing DuMathijs BaensIngrid J. Apel
- Cited by
- AgingCancer ResearchImmunology
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Alex Appert
17 papers receiving 686 citations
Peers
Comparison fields: 5 of 77
- Aging 175
- Cancer Research 165
- Immunology 152
- Molecular Biology 444
- Pathology and Forensic Medicine 97
Countries citing papers authored by Alex Appert
This map shows the geographic impact of Alex Appert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Appert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Appert more than expected).
Fields of papers citing papers by Alex Appert
This network shows the impact of papers produced by Alex Appert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Appert. The network helps show where Alex Appert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alex Appert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2022 | 6 | |
| 3 | 2021 | 10 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 13 | |
| 6 | 2019 | 35 | |
| 7 | 2018 | 62 | |
| 8 | 2017 | 82 | |
| 9 | 2015 | 47 | |
| 10 | 2013 | 25 | |
| 11 | 2012 | 62 | |
| 12 | 2011 | 50 | |
| 13 | 2011 | 120 | |
| 14 | 2010 | 89 | |
| 15 | 2009 | 36 | |
| 16 | 2008 | 36 | |
| 17 | Factors X Nice I and II: two novel missense mutations (Met-40Val and Pro304Ser) in patient with coagulation factor X deficiency. | 1998 | 7 |
About Alex Appert
Alex Appert is a scholar working on Aging, Cancer Research, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 17 papers that have together received 689 indexed citations. Recurring topics across this work include Genetics, Aging, and Longevity in Model Organisms (7 papers), NF-κB Signaling Pathways (4 papers), Genomics and Chromatin Dynamics (4 papers), CRISPR and Genetic Engineering (3 papers), Epigenetics and DNA Methylation (3 papers), Lymphoma Diagnosis and Treatment (3 papers), CAR-T cell therapy research (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Aging (175 citations), Cancer Research (165 citations), Immunology (152 citations), Molecular Biology (444 citations) and Pathology and Forensic Medicine (97 citations). Alex Appert has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Julie Ahringer, Przemysław Stempor, Dong Yan, Rifat Hamoudi, Ni Huang, Ming‐Qing Du, Mathijs Baens, Ingrid J. Apel, Peter C. Lucas and Shaun Rosebeck. Their work appears in journals such as PLoS Genetics, eLife, Oncogene, Genes & Development and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.